Registered Number:14578273 |
For the period 09 January 2023 to 31 January 2024
England and Wales
Unaudited Financial Statements
For the period 09 January 2023 to 31 January 2024
JEMIMAPHARMA LIMITED
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
JEMIMAPHARMA LIMITED
Statement of Financial Position
2024
Property, plant and equipment |
14,219
2
14,219
Trade and other receivables |
6,000
3
Cash and cash equivalents |
19,654
25,654
Trade and other payables: amounts falling due within one |
year |
(31,755)
4
(6,101)
Net current liabilities
Total assets less current liabilities |
8,118
8,118
Net assets/liabilities
100
8,018
8,118
Shareholders' funds
For the period 09 January 2023 to 31 January 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the period 09 January 2023 to 31 January 2024 in accordance with Section 476 of the Companies Act 2006 |
The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
HEENA JEMIMA CHOWDRY Director |
These financial statements were approved and authorised for issue by the Board on 08 October 2024 and were signed by: |
The notes form part of these financial statements |
1 of 3
For the period 09 January 2023 to 31 January 2024
JEMIMAPHARMA LIMITED
Notes to the Financial Statements
Statutory Information
JEMIMAPHARMA LIMITED is a private limited company, limited by shares, domiciled in England and Wales, |
registration number 14578273. |
THE RECTORY CHURCH LANE
NORTH OCKENDON
UPMINSTER
ESSEX
RM14 3QH
The presentation currency is £ sterling. |
Basis of preparing the financial statements
2. Property, plant and equipment |
16,728
16,728
Provision for depreciation and impairment |
Charge for period
2,509
2,509
14,219
3. Trade and other receivables |
2024
6,000
4. Trade and other payables: amounts falling due within one year |
2024
Taxation and social security |
2,594
29,161
31,755
2 of 3
For the period 09 January 2023 to 31 January 2024
JEMIMAPHARMA LIMITED
Notes to the Financial Statements Continued
5. Average number of persons employed |
During the year the average number of employees was 2
3 of 3